Investigation of the relationship between IL-6 and type 2 biomarkers in patients with severe asthma.
Where this comes from
- Record sourced from PubMed, PMID 31513878.
- Also identified by DOI 10.1016/j.jaci.2019.08.031 and PMC identifier 7469890.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Combination of IL-6 (non-Type 2 asthma) and FeNO or blood eosinophil count (Type 2 asthma) identified asthma endotypes related to asthma severity, exacerbations, and responsiveness to corticosteroids and potential for response to anti-Type 2 and anti-IL-6 treatment.
Medical subject headings
- Asthma
- Interleukin-6